CUSIP 03237H101 · who reports it, how much, and how much it matters to them
32 of the 720 hedge fund managers we track reported shares of Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) on Form 13F for 30 June 2026. Between them they reported USD 331m. The largest position belongs to Perceptive Advisors, at USD 150m. The manager with the most riding on it is Almitas Capital, where it is 4.2% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Perceptive Advisors6 funds on PPLI.com | USD 150m | 2.2% |
| 2 | Adage Capital Management1 fund on PPLI.com | USD 34m | 0.0% |
| 3 | 683 Capital Management2 funds on PPLI.com | USD 23m | 1.1% |
| 4 | Almitas Capital2 funds on PPLI.com | USD 18m | 4.2% |
| 5 | Boxer Capital Management1 fund on PPLI.com | USD 14m | 1.1% |
| 6 | Great Point Partners2 funds on PPLI.com | USD 13m | 2.4% |
| 7 | Balyasny Asset Management25 funds on PPLI.com | USD 12m | 0.0% |
| 8 | Two Sigma Investments35 funds on PPLI.com | USD 11m | 0.0% |
| 9 | Rock Springs Capital Management2 funds on PPLI.com | USD 9m | 0.4% |
| 10 | HighVista Strategies27 funds on PPLI.com | USD 6.9m | 1.6% |
| 11 | Logos Global Management1 fund on PPLI.com | USD 6.3m | 0.3% |
| 12 | Cormorant Asset Management1 fund on PPLI.com | USD 3.6m | 0.2% |
| 13 | Walleye Capital8 funds on PPLI.com | USD 3.4m | 0.0% |
| 14 | Orbimed Advisors1 fund on PPLI.com | USD 3.3m | 0.1% |
| 15 | Citadel Advisors32 funds on PPLI.com | USD 3.2m | 0.0% |
| 16 | D. E. Shaw & Co.15 funds on PPLI.com | USD 3.1m | 0.0% |
| 17 | Acuta Capital Partners2 funds on PPLI.com | USD 3m | 2.1% |
| 18 | Alpha Wave Global1 fund on PPLI.com | USD 2.8m | 0.0% |
| 19 | PFM Health Sciences3 funds on PPLI.com | USD 2.6m | 0.2% |
| 20 | Lighthouse Investment Partners190 funds on PPLI.com | USD 2.2m | 0.1% |
| 21 | Campbell & Company Investment Adviser8 funds on PPLI.com | USD 1.8m | 0.1% |
| 22 | Schonfeld Strategic Advisors30 funds on PPLI.com | USD 1.2m | 0.0% |
| 23 | Hudson Bay Capital Management8 funds on PPLI.com | USD 898,000 | 0.0% |
| 24 | Aquatic Capital Management3 funds on PPLI.com | USD 708,000 | 0.0% |
| 25 | Boothbay Fund Management2 funds on PPLI.com | USD 648,000 | 0.0% |
| 26 | Tudor Investment Corporation10 funds on PPLI.com | USD 636,000 | 0.0% |
| 27 | Jain Global1 fund on PPLI.com | USD 517,000 | 0.0% |
| 28 | Graham Capital Management18 funds on PPLI.com | USD 222,000 | 0.0% |
| 29 | Magnetar Financial93 funds on PPLI.com | USD 211,000 | 0.0% |
| 30 | Brevan Howard Capital Management39 funds on PPLI.com | USD 209,000 | 0.0% |
| 31 | Fulcrum Asset Management LLP7 funds on PPLI.com | USD 82,280 | 0.0% |
| 32 | The Quarry1 fund on PPLI.com | USD 2,496 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Almitas Capital | USD 18m | 4.2% |
| 2 | Great Point Partners | USD 13m | 2.4% |
| 3 | Perceptive Advisors | USD 150m | 2.2% |
| 4 | Acuta Capital Partners | USD 3m | 2.1% |
| 5 | HighVista Strategies | USD 6.9m | 1.6% |
| 6 | 683 Capital Management | USD 23m | 1.1% |
| 7 | Boxer Capital Management | USD 14m | 1.1% |
| 8 | Rock Springs Capital Management | USD 9m | 0.4% |
| 9 | Logos Global Management | USD 6.3m | 0.3% |
| 10 | PFM Health Sciences | USD 2.6m | 0.2% |
Amylyx Pharmaceuticals, Inc. trades under the symbol AMLX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 03237H101.
32 of the 720 hedge fund managers PPLI.com tracks reported Amylyx Pharmaceuticals, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Perceptive Advisors (USD 150m), Adage Capital Management (USD 34m), 683 Capital Management (USD 23m), Almitas Capital (USD 18m) and Boxer Capital Management (USD 14m).
32 managers in our coverage reported it, and between them they run 577 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Almitas Capital, where the position was 4.2% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Amylyx Pharmaceuticals, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.